
The State-of-TRT 2026: Helping APPs & Their Patients Manage TRT, Not Just Start It
Inaugural Landmark APP Study, Conducted in Partnership with SERMO
Saturday, October 10, 2026
7:00 - 8:00 AM
Program Objectives:
- Review key market trends from the inaugural study of more than 200 U.S. advanced practice providers (APPs) experienced in testosterone replacement therapy (TRT)
- Explore how guideline usage varies between APPs and implications for TRT management
- Discuss how the removal of the testosterone Black Box Warning may be influencing clinical decision making
- Discuss upcoming regulatory changes to TRT and implications for healthcare professionals and patients

Basil Z. Kaaki, DMSc, PA-CSpeaker
Assistant Professor
Program Director: APP Men's Health and Sexual Medicine Preceptorship, Scott Department of Urology, Baylor College of Medicine
Houston, Texas

Patrick Dougherty, MPAS, PA-CSpeaker
Physician Assistant
UT Southwestern Medical Center, Department of Urology
Dallas, Texas
Dallas, Texas

Charity L. Gardner, APRN-FNP-CSpeaker
Nurse Practitioner
Amarillo Urology Associates
Amarillo, Texas
Amarillo Urology Associates
Amarillo, Texas

Henry M. Vanpala, DNP, AGNP-CSpeaker
Nurse Practitioner
Amarillo Urology Associates
Amarillo, Texas
Amarillo Urology Associates
Amarillo, Texas